×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Incathlab member and receive full access to its content!

You must be an Incathlab member to access videos without any restrictions. Register for free in one minute and access all services provided by Incathlab.You will also be able to log into Incathlab from your Facebook or twitter account by clicking on login on the top-right corner of Incathlab website.

Registration Login


Worldwide schedules comment Share
35861 views

The benefits of lower-profile devices are obvious. Not only can more patients with smaller access vessels be treated without the need for conduit access or bypass graft surgery, but access site complications are lower the smaller the device, and more can be done percutaneously without the need for surgical arteriotomy for access.
Discover in this webinar the ultra-low profile abdominal aortic aneurysm stent graft system, which demonstrated to be easy to use, accurate in placement and effective in navigational challenges.

Program

12:30 Product Review & 5 years Innovation study results - Dr Llaneza
12:45 1st Case "Narrow access case" - Panel Discussion
Dr Llaneza, Dr del Castro and Dr Alonso
13:15 Incraft® Concept: an advantage ONLY for complex access? - Dr del Castro
           Preserve Hypogastric - IN Situ Sizing
           Short Necks - Deployment accuracy
13:25 2nd Case"Hypogastric preservation case" - Panel Discussion
Dr Llaneza, Dr del Castro and Dr Alonso
13:55 Closing & Remarks

 

Educational objectives

  • Discuss current use of ultra-low profile Incraft® AAA stent graft systems
  • Learn from expert discussion of the patients’ outcomes with low profile Incraft® AAA  stent graft system treatment 
  • Demonstrate advanced techniques in the treatment of aortic disease
  • Demonstrate new tools available
  • Provide platform for discussion and mutual learning

​Bibliography

Audience

  • Endovascular specialists (Vascular Surgeons, Interventional Radiologists, Interventional Angiologists and Interventional Cardiologists)
  • Referring physicians of patients with vascular disease
     
IMPORTANT NOTICE
 
This webinar is an educational event supported by Cordis Corporation, and is intended for Healthcare Professionals in Europe Middle East and Africa. 
The use of the INCRAFT® AAA Stent-Graft System requires that physicians be specially trained in endovascular abdominal aortic aneurysm repair techniques, including experience with high resolution fluoroscopy and radiation safety. Cordis Corporation will provide training specific to the INCRAFT® AAA Stent-Graft System.
The INCRAFT® System is currently approved for investigational device use only in the U.S. and Japan and is being studied in a global pivotal clinical study in the U.S. and Japan called the INSPIRATION Trial, which completed enrollment in 2013.
 
While every effort is made to see that no inaccurate or misleading data, opinions, or statements appear in this webinar, Cordis Corporation wish to make it clear that material contained in the webinar represents independent evaluations and opinions of the authors and contributors. As a consequence, Cordis Corporation accepts no responsibility for the consequences of any such inaccurate or misleading data or statements. Neither do they endorse the content or the use of any drug or medical device in a way that lies outside its current licensed application in any territory. This presentation may include the demonstration of the use of medical devices; it is not intended to be used as a training guide. The steps demonstrated may not be the complete steps of the procedure. Individual preference and experience, as well as patient needs, may dictate variation in procedure steps. Before using any medical device, including those demonstrated or referenced in this webinar, review all relevant package inserts, with particular attention to the indications, contraindications, warnings and precautions, and steps for use of the device.
 
All content in these presentations is owned by their authors and is protected by worldwide copyright laws. No modification or further reproduction of the content is permitted. 
Dr Manuel Alonso,  Dr Llaneza and Dr  Del Castro  are  compensated by and presenting on behalf of Cordis. 
 
For Healthcare Professionals Only. 
©2017 Cardinal Health. 
Cordis, Cordis LOGO and INCRAFT are trademarks or registered trademarks of Cardinal Health.
 
EU2321 05/17
Shooting date : 2017-05-24
Last update : 2017-08-29
5 comments
Join the Discussion
  • Martin R. Thanks for your presentation. Do you believe an RCT is needed to demonstrate benefits of PEVAR vs opening the groin?

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    • Enrique P. the overlapping zone...should be the same in both limbs ??

      • José Antonio D. Sorry for not answering your question in the live session. Overlapping can be adjusted independently in each limb. The ipsilateral limb is approximately 1cm longer than the contralateral limb. From the end of each limb there is a 2 cm minimum overlapping for both, and other 3 cm proximally in the ipsilateral limb (5 cm total) / 2 cm contralateral (4 cm total), with which you can "play" and adjust the length as necessary.

        Un abrazo desde Oviedo.

      • Angelo D. Very good procedure! Yesterday we performed two PEVAR using Incraft. I think it's better same limbs overlapping zone in case of excessive aortic angles at the level of the distal portion of the main body

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    • Alexandre Coutinho . Thank you to share the cases. Best regards

        Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
        Your browser doesn't have Flash, Silverlight or HTML5 support.


      Suggestions

      Monday, December 7th 2020 from 05pm to 06:30pm (GMT+1)
      Honolulu : Monday, December 7th 2020 from 06am to 07:30am (GMT-10)
      San Francisco : Monday, December 7th 2020 from 08am to 09:30am (GMT-8)
      New York : Monday, December 7th 2020 from 11am to 12:30pm (GMT-5)
      Buenos Aires : Monday, December 7th 2020 from 01pm to 02:30pm (GMT-3)
      London / Dublin : Monday, December 7th 2020 from 04pm to 05:30pm (GMT)
      Paris / Berlin : Monday, December 7th 2020 from 05pm to 06:30pm (GMT+1)
      Istanbul : Monday, December 7th 2020 from 06pm to 07:30pm (GMT+2)
      Moscou / Dubaï : Monday, December 7th 2020 from 08pm to 09:30pm (GMT+4)
      Bangkok : Monday, December 7th 2020 from 11pm to 12:30am (GMT+7)
      Shanghai : Tuesday, December 8th 2020 from 12am to 01:30am (GMT+8)
      Tokyo : Tuesday, December 8th 2020 from 01am to 02:30am (GMT+9)
      Sydney : Tuesday, December 8th 2020 from 02am to 03:30am (GMT+10)
      Wellington : Tuesday, December 8th 2020 from 04am to 05:30am (GMT+12)

      CLI across the globe – a transatlantic discussion

      Share
      Wednesday, December 16th 2020 from 05pm to 06:15pm (GMT+1)
      Honolulu : Wednesday, December 16th 2020 from 06am to 07:15am (GMT-10)
      San Francisco : Wednesday, December 16th 2020 from 08am to 09:15am (GMT-8)
      New York : Wednesday, December 16th 2020 from 11am to 12:15pm (GMT-5)
      Buenos Aires : Wednesday, December 16th 2020 from 01pm to 02:15pm (GMT-3)
      London / Dublin : Wednesday, December 16th 2020 from 04pm to 05:15pm (GMT)
      Paris / Berlin : Wednesday, December 16th 2020 from 05pm to 06:15pm (GMT+1)
      Istanbul : Wednesday, December 16th 2020 from 06pm to 07:15pm (GMT+2)
      Moscou / Dubaï : Wednesday, December 16th 2020 from 08pm to 09:15pm (GMT+4)
      Bangkok : Wednesday, December 16th 2020 from 11pm to 12:15am (GMT+7)
      Shanghai : Thursday, December 17th 2020 from 12am to 01:15am (GMT+8)
      Tokyo : Thursday, December 17th 2020 from 01am to 02:15am (GMT+9)
      Sydney : Thursday, December 17th 2020 from 02am to 03:15am (GMT+10)
      Wellington : Thursday, December 17th 2020 from 04am to 05:15am (GMT+12)

      No CTO in peripheral arteries is too difficult to be crossed

      tips and tricks to succeed in your interventions

      Share
      Monday, December 14th 2020 from 06pm to 07pm (GMT+1)
      Honolulu : Monday, December 14th 2020 from 07am to 08am (GMT-10)
      San Francisco : Monday, December 14th 2020 from 09am to 10am (GMT-8)
      New York : Monday, December 14th 2020 from 12pm to 01pm (GMT-5)
      Buenos Aires : Monday, December 14th 2020 from 02pm to 03pm (GMT-3)
      London / Dublin : Monday, December 14th 2020 from 05pm to 06pm (GMT)
      Paris / Berlin : Monday, December 14th 2020 from 06pm to 07pm (GMT+1)
      Istanbul : Monday, December 14th 2020 from 07pm to 08pm (GMT+2)
      Moscou / Dubaï : Monday, December 14th 2020 from 09pm to 10pm (GMT+4)
      Bangkok : Tuesday, December 15th 2020 from 12am to 01am (GMT+7)
      Shanghai : Tuesday, December 15th 2020 from 01am to 02am (GMT+8)
      Tokyo : Tuesday, December 15th 2020 from 02am to 03am (GMT+9)
      Sydney : Tuesday, December 15th 2020 from 03am to 04am (GMT+10)
      Wellington : Tuesday, December 15th 2020 from 05am to 06am (GMT+12)

      Intravascular Lithotripsy (IVL): a superior pathway in calcified PAD treatment

      Disrupt PADIII the first level 1 evidence in severely calcified lesions.

      Share
      Wednesday, March 10th 2021 from 05pm to 06:30pm (GMT+1)
      Honolulu : Wednesday, March 10th 2021 from 06am to 07:30am (GMT-10)
      San Francisco : Wednesday, March 10th 2021 from 08am to 09:30am (GMT-8)
      New York : Wednesday, March 10th 2021 from 11am to 12:30pm (GMT-5)
      Buenos Aires : Wednesday, March 10th 2021 from 01pm to 02:30pm (GMT-3)
      London / Dublin : Wednesday, March 10th 2021 from 04pm to 05:30pm (GMT)
      Paris / Berlin : Wednesday, March 10th 2021 from 05pm to 06:30pm (GMT+1)
      Istanbul : Wednesday, March 10th 2021 from 06pm to 07:30pm (GMT+2)
      Moscou / Dubaï : Wednesday, March 10th 2021 from 08pm to 09:30pm (GMT+4)
      Bangkok : Wednesday, March 10th 2021 from 11pm to 12:30am (GMT+7)
      Shanghai : Thursday, March 11th 2021 from 12am to 01:30am (GMT+8)
      Tokyo : Thursday, March 11th 2021 from 01am to 02:30am (GMT+9)
      Sydney : Thursday, March 11th 2021 from 02am to 03:30am (GMT+10)
      Wellington : Thursday, March 11th 2021 from 04am to 05:30am (GMT+12)

      CLI across the globe – Second Edition

      A Critical Multidisciplinary Discussion

      Share
      Tuesday, March 23rd 2021 from 01pm to 02pm (GMT+1)
      Honolulu : Tuesday, March 23rd 2021 from 02am to 03am (GMT-10)
      San Francisco : Tuesday, March 23rd 2021 from 04am to 05am (GMT-8)
      New York : Tuesday, March 23rd 2021 from 07am to 08am (GMT-5)
      Buenos Aires : Tuesday, March 23rd 2021 from 09am to 10am (GMT-3)
      London / Dublin : Tuesday, March 23rd 2021 from 12pm to 01pm (GMT)
      Paris / Berlin : Tuesday, March 23rd 2021 from 01pm to 02pm (GMT+1)
      Istanbul : Tuesday, March 23rd 2021 from 02pm to 03pm (GMT+2)
      Moscou / Dubaï : Tuesday, March 23rd 2021 from 04pm to 05pm (GMT+4)
      Bangkok : Tuesday, March 23rd 2021 from 07pm to 08pm (GMT+7)
      Shanghai : Tuesday, March 23rd 2021 from 08pm to 09pm (GMT+8)
      Tokyo : Tuesday, March 23rd 2021 from 09pm to 10pm (GMT+9)
      Sydney : Tuesday, March 23rd 2021 from 10pm to 11pm (GMT+10)
      Wellington : Wednesday, March 24th 2021 from 12am to 01am (GMT+12)

      From Access to Closure: Strategies for successful management of multilevel CLI disease

      Learn from the experts about managing multilevel disease from Access to closure and the multidiscipl...

      Share
      Tuesday, April 6th 2021 from 05pm to 06pm (GMT+1)
      Honolulu : Tuesday, April 6th 2021 from 06am to 07am (GMT-10)
      San Francisco : Tuesday, April 6th 2021 from 09am to 10am (GMT-7)
      New York : Tuesday, April 6th 2021 from 12pm to 01pm (GMT-4)
      Buenos Aires : Tuesday, April 6th 2021 from 01pm to 02pm (GMT-3)
      Reykjavik : Tuesday, April 6th 2021 from 04pm to 05pm (GMT)
      London / Dublin : Tuesday, April 6th 2021 from 05pm to 06pm (GMT+1)
      Paris / Berlin : Tuesday, April 6th 2021 from 06pm to 07pm (GMT+2)
      Istanbul : Tuesday, April 6th 2021 from 07pm to 08pm (GMT+3)
      Moscou / Dubaï : Tuesday, April 6th 2021 from 08pm to 09pm (GMT+4)
      Bangkok : Tuesday, April 6th 2021 from 11pm to 12am (GMT+7)
      Shanghai : Wednesday, April 7th 2021 from 12am to 01am (GMT+8)
      Tokyo : Wednesday, April 7th 2021 from 01am to 02am (GMT+9)
      Sydney : Wednesday, April 7th 2021 from 03am to 04am (GMT+11)
      Wellington : Wednesday, April 7th 2021 from 05am to 06am (GMT+13)

      Welche Rolle kann direktionale Atherektomie in meinem Cath Lab zur Behandlung verkalkter pAVK Läsio...

      Bedeutung der DAART-Strategie für bessere Ergebnisse bei pAVK.

      Share
      Friday, February 23rd 2024 from 11am to 12:30pm (GMT+1)
      Honolulu : Friday, February 23rd 2024 from 12am to 01:30am (GMT-10)
      San Francisco : Friday, February 23rd 2024 from 02am to 03:30am (GMT-8)
      New York : Friday, February 23rd 2024 from 05am to 06:30am (GMT-5)
      Buenos Aires : Friday, February 23rd 2024 from 07am to 08:30am (GMT-3)
      London / Dublin : Friday, February 23rd 2024 from 10am to 11:30am (GMT)
      Paris / Berlin : Friday, February 23rd 2024 from 11am to 12:30pm (GMT+1)
      Istanbul : Friday, February 23rd 2024 from 12pm to 01:30pm (GMT+2)
      Moscou / Dubaï : Friday, February 23rd 2024 from 02pm to 03:30pm (GMT+4)
      Bangkok : Friday, February 23rd 2024 from 05pm to 06:30pm (GMT+7)
      Shanghai : Friday, February 23rd 2024 from 06pm to 07:30pm (GMT+8)
      Tokyo : Friday, February 23rd 2024 from 07pm to 08:30pm (GMT+9)
      Sydney : Friday, February 23rd 2024 from 08pm to 09:30pm (GMT+10)
      Wellington : Friday, February 23rd 2024 from 10pm to 11:30pm (GMT+12)

      Realizing the PAD Workflow of the Future

      A more efficient and Versatile Approach to Complex Lesions

      Share
      Thursday, November 4th 2021 from 05pm to 06:15pm (GMT+1)
      Honolulu : Thursday, November 4th 2021 from 06am to 07:15am (GMT-10)
      San Francisco : Thursday, November 4th 2021 from 08am to 09:15am (GMT-8)
      New York : Thursday, November 4th 2021 from 11am to 12:15pm (GMT-5)
      Buenos Aires : Thursday, November 4th 2021 from 01pm to 02:15pm (GMT-3)
      London / Dublin : Thursday, November 4th 2021 from 04pm to 05:15pm (GMT)
      Paris / Berlin : Thursday, November 4th 2021 from 05pm to 06:15pm (GMT+1)
      Istanbul : Thursday, November 4th 2021 from 06pm to 07:15pm (GMT+2)
      Moscou / Dubaï : Thursday, November 4th 2021 from 08pm to 09:15pm (GMT+4)
      Bangkok : Thursday, November 4th 2021 from 11pm to 12:15am (GMT+7)
      Shanghai : Friday, November 5th 2021 from 12am to 01:15am (GMT+8)
      Tokyo : Friday, November 5th 2021 from 01am to 02:15am (GMT+9)
      Sydney : Friday, November 5th 2021 from 02am to 03:15am (GMT+10)
      Wellington : Friday, November 5th 2021 from 04am to 05:15am (GMT+12)

      Challenges of fempop interventions – Crossing of complex lesions and preventing restenosis

      Swirling Flow: a replacement for anti-proliferative coating?

      Share
      Scroll Up